Gender dysphoria; transsexualism; male to female MtF transsexual; female to male FtM transsexual; trans man; trans woman; transman; transwoman. Gender identity disorder is a strong and persistent feeling that a person has the wrong gender identification, which causes discomfort with their sex or a sense of inappropriateness in the gender role of that sex. In addition, a person with this disorder wants to live and be accepted as a member of the opposite sex and change the gender of his or her body as far as possible through surgery and hormone treatment. The underlying cause for gender identity disorder is unknown. In animals, it is known that there are critical periods of time during pregnancy where alterations in the amount of oestrogen and testosterone in the developing animal can permanently alter masculine or feminine behaviour. However, more research is needed to find out if a similar mechanism could be operating in gender identity disorder.
Mortality and morbidity in transsexual patients with cross-gender hormone treatment.
Gender identity disorder | You and Your Hormones from the Society for Endocrinology
The treatment for transsexualism is sex reassignment, including hormonal treatment and surgery aimed at making the person's body as congruent with the opposite sex as possible. There is a dearth of long term, follow-up studies after sex reassignment. To estimate mortality, morbidity, and criminal rate after surgical sex reassignment of transsexual persons. All sex-reassigned persons male-to-females, female-to-males in Sweden, —
Psychological evaluation has shown that sex reassignment increases the well-being of transsexual subjects 1 , 2 , 3. Cross-sex hormone treatment has an important role in acquiring the secondary sex characteristics of the desired sex 4. Transsexuals often start taking sex hormones at young to middle age and in higher than recommended dosages. Fearing loss of secondary characteristics of the reassigned sex, transsexual subjects usually continue hormones lifelong.
Skip to search form Skip to main content. Mortality and morbidity in transsexual patients with cross-gender hormone treatment. The number of deaths and morbidity cases in transsexual patients treated with cross-gender hormones were evaluated retrospectively and compared with the expected number in a similar reference group of the population. The number of deaths in male-to-female transsexuals was five times the number expected, due to increased numbers of suicide and death of unknown cause. View on PubMed.